KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Charles River Laboratories International (CRL) Short-term Investments: 2010-2011

Charles River Laboratories International's Short-term Investments was N/A to $6.2 million in Q3 2011 from the same period last year, while for Sep 2011 it was $6.2 million, marking a year-over-year change of. This contributed to the annual value of $9.8 million for FY2010, which is N/A change from last year.
Charles River Laboratories International's Short-term Investments amounted to $6.2 million in Q3 2011, which was down 47.47% from $11.8 million recorded in Q2 2011.
In the past 5 years, Charles River Laboratories International's Short-term Investments ranged from a high of $11.8 million in Q2 2011 and a low of $6.2 million during Q3 2011.
Moreover, its 2-year median value for Short-term Investments was $9.8 million (2010), whereas its average is $9.3 million.